LT - Chinazolino darinio ZD6474 derinio su gemcitabinu ir, nebūtinai, jonizuojančia radiacija panaudojimas vėžio gydymui
EN - USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH GEMCITABINE AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF CANCER
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/517 |
(2006.01) |
|
|
A61K 31/7068 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
1551409 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
03751032.8 |
|
Date of filing the European patent application |
2003-10-06 |
| (97) |
Date of publication of the European application |
2005-07-13 |
| (45) |
Date of publication and mention of the grant of the patent |
2007-03-21
|
| (46) |
Date of publication of the claims translation |
2007-06-26
|
PCT application
| (86) |
Number |
PCT/GB2003/004334 |
|
Date |
2003-10-06 |
PCT application publication
| (87) |
Number |
WO 2004/032937 |
|
Date |
2004-04-22 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
0223380 |
2002-10-09
|
GB |
Inventors
| (72) |
BARGE, Alan, AstraZeneca R & D Alderley, GB
|
Grantee
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
Attorney or representative
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
Title
| (54) |
Chinazolino darinio ZD6474 derinio su gemcitabinu ir, nebūtinai, jonizuojančia radiacija panaudojimas vėžio gydymui |
| |
USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH GEMCITABINE AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF CANCER |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2012-09-18 |
10 |
800.00
LTL
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2013-10-06 |
